Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 12 | 2023 | 421 | 5.350 |
Why?
|
Lenses, Intraocular | 6 | 2022 | 142 | 1.980 |
Why?
|
Vitreous Detachment | 2 | 2023 | 22 | 1.770 |
Why?
|
Lens Implantation, Intraocular | 6 | 2022 | 193 | 1.670 |
Why?
|
Retinal Detachment | 4 | 2023 | 411 | 1.510 |
Why?
|
Retinal Degeneration | 2 | 2024 | 414 | 1.370 |
Why?
|
Endophthalmitis | 4 | 2022 | 263 | 1.360 |
Why?
|
Retinal Vessels | 9 | 2024 | 769 | 1.330 |
Why?
|
Ophthalmology | 4 | 2022 | 506 | 1.260 |
Why?
|
Macular Edema | 2 | 2022 | 359 | 1.250 |
Why?
|
Eye Infections, Bacterial | 3 | 2019 | 235 | 1.170 |
Why?
|
Sclera | 5 | 2022 | 200 | 1.110 |
Why?
|
Intravitreal Injections | 9 | 2022 | 345 | 1.100 |
Why?
|
Fluorescein Angiography | 12 | 2024 | 936 | 1.100 |
Why?
|
Visual Acuity | 14 | 2023 | 2520 | 1.070 |
Why?
|
Retinal Perforations | 2 | 2024 | 131 | 1.030 |
Why?
|
Diabetic Retinopathy | 3 | 2022 | 1205 | 0.990 |
Why?
|
Eye Injuries | 3 | 2023 | 245 | 0.920 |
Why?
|
Retinoschisis | 4 | 2023 | 30 | 0.900 |
Why?
|
Aicardi Syndrome | 1 | 2023 | 17 | 0.890 |
Why?
|
Geographic Atrophy | 1 | 2023 | 66 | 0.880 |
Why?
|
Scleral Diseases | 1 | 2022 | 22 | 0.850 |
Why?
|
Tomography, Optical Coherence | 15 | 2024 | 2637 | 0.840 |
Why?
|
Hemangioblastoma | 1 | 2022 | 70 | 0.830 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2019 | 2638 | 0.820 |
Why?
|
Angiogenesis Inhibitors | 9 | 2022 | 2038 | 0.810 |
Why?
|
Optic Disk | 2 | 2023 | 401 | 0.810 |
Why?
|
von Hippel-Lindau Disease | 1 | 2022 | 152 | 0.780 |
Why?
|
Turner Syndrome | 1 | 2022 | 130 | 0.780 |
Why?
|
Myopia | 1 | 2024 | 254 | 0.780 |
Why?
|
Retinal Neoplasms | 1 | 2022 | 144 | 0.750 |
Why?
|
Ophthalmologic Surgical Procedures | 3 | 2020 | 349 | 0.720 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 52 | 0.710 |
Why?
|
Keratitis | 2 | 2020 | 268 | 0.690 |
Why?
|
Spasms, Infantile | 1 | 2023 | 305 | 0.670 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2019 | 120 | 0.670 |
Why?
|
Infant, Low Birth Weight | 2 | 2022 | 850 | 0.670 |
Why?
|
Resistance Training | 1 | 2020 | 164 | 0.660 |
Why?
|
Retina | 12 | 2023 | 2611 | 0.650 |
Why?
|
Retinal Diseases | 5 | 2023 | 683 | 0.640 |
Why?
|
Lens, Crystalline | 1 | 2020 | 388 | 0.640 |
Why?
|
Fluorocarbons | 1 | 2023 | 452 | 0.640 |
Why?
|
Peptide Nucleic Acids | 1 | 2017 | 24 | 0.610 |
Why?
|
Conjunctivitis, Allergic | 1 | 2018 | 129 | 0.600 |
Why?
|
Gestational Age | 6 | 2023 | 3490 | 0.590 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 580 | 0.580 |
Why?
|
Cysts | 1 | 2022 | 676 | 0.570 |
Why?
|
Retinal Vein Occlusion | 3 | 2023 | 137 | 0.550 |
Why?
|
Social Justice | 1 | 2020 | 455 | 0.540 |
Why?
|
Mitochondrial Diseases | 1 | 2019 | 321 | 0.540 |
Why?
|
Vitrectomy | 6 | 2024 | 365 | 0.520 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1017 | 0.520 |
Why?
|
Muscular Diseases | 1 | 2019 | 557 | 0.510 |
Why?
|
Device Removal | 2 | 2019 | 652 | 0.510 |
Why?
|
Infant, Newborn | 14 | 2023 | 25575 | 0.490 |
Why?
|
Fundus Oculi | 5 | 2023 | 472 | 0.470 |
Why?
|
Choroid | 3 | 2020 | 317 | 0.460 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5724 | 0.460 |
Why?
|
Vascular Endothelial Growth Factor A | 7 | 2022 | 3502 | 0.450 |
Why?
|
Retrospective Studies | 31 | 2024 | 77098 | 0.430 |
Why?
|
Fovea Centralis | 3 | 2023 | 118 | 0.400 |
Why?
|
Epiretinal Membrane | 2 | 2022 | 68 | 0.400 |
Why?
|
Incontinentia Pigmenti | 2 | 2022 | 10 | 0.390 |
Why?
|
Atrophy | 3 | 2024 | 1576 | 0.370 |
Why?
|
Humans | 79 | 2024 | 742088 | 0.370 |
Why?
|
Macula Lutea | 2 | 2023 | 151 | 0.370 |
Why?
|
Vitreoretinal Surgery | 2 | 2020 | 27 | 0.360 |
Why?
|
Disease Management | 1 | 2020 | 2450 | 0.350 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1449 | 0.340 |
Why?
|
Caregivers | 1 | 2020 | 2074 | 0.330 |
Why?
|
Laser Coagulation | 2 | 2022 | 326 | 0.330 |
Why?
|
Uveitis | 2 | 2022 | 375 | 0.320 |
Why?
|
Bacteria | 1 | 2019 | 2102 | 0.320 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1398 | 0.320 |
Why?
|
Oxygen | 1 | 2019 | 4169 | 0.310 |
Why?
|
Birth Weight | 4 | 2023 | 2068 | 0.300 |
Why?
|
Suture Techniques | 3 | 2021 | 797 | 0.290 |
Why?
|
Child | 16 | 2024 | 77478 | 0.280 |
Why?
|
Optic Neuritis | 2 | 2020 | 166 | 0.280 |
Why?
|
Strabismus | 2 | 2021 | 287 | 0.270 |
Why?
|
Comprehension | 2 | 2021 | 608 | 0.260 |
Why?
|
Infant, Premature | 3 | 2023 | 2041 | 0.260 |
Why?
|
Prosthesis Failure | 2 | 2020 | 1203 | 0.250 |
Why?
|
Macular Degeneration | 2 | 2022 | 980 | 0.240 |
Why?
|
Female | 34 | 2023 | 379592 | 0.230 |
Why?
|
Eye Pain | 2 | 2020 | 47 | 0.230 |
Why?
|
Phacoemulsification | 2 | 2022 | 149 | 0.220 |
Why?
|
Vision Tests | 1 | 2023 | 167 | 0.220 |
Why?
|
Glaucoma | 2 | 2023 | 1152 | 0.220 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2022 | 58 | 0.220 |
Why?
|
Vigabatrin | 1 | 2023 | 92 | 0.210 |
Why?
|
Contrast Sensitivity | 1 | 2023 | 244 | 0.210 |
Why?
|
Liver Abscess | 1 | 2022 | 82 | 0.210 |
Why?
|
Eye Injuries, Penetrating | 1 | 2023 | 115 | 0.200 |
Why?
|
Capillaries | 2 | 2022 | 774 | 0.200 |
Why?
|
Dissection | 1 | 2023 | 294 | 0.200 |
Why?
|
Beckwith-Wiedemann Syndrome | 1 | 2021 | 43 | 0.200 |
Why?
|
Klebsiella Infections | 1 | 2022 | 137 | 0.200 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2187 | 0.200 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 664 | 0.200 |
Why?
|
Astigmatism | 1 | 2021 | 70 | 0.200 |
Why?
|
Male | 28 | 2023 | 349538 | 0.190 |
Why?
|
Retinal Neovascularization | 2 | 2020 | 244 | 0.190 |
Why?
|
Carcinosarcoma | 1 | 2021 | 108 | 0.190 |
Why?
|
Retinitis | 1 | 2020 | 35 | 0.190 |
Why?
|
Fragile X Syndrome | 1 | 2022 | 115 | 0.190 |
Why?
|
Nematoda | 1 | 2020 | 29 | 0.190 |
Why?
|
Eye Infections, Parasitic | 1 | 2020 | 24 | 0.190 |
Why?
|
Glaucoma, Neovascular | 1 | 2020 | 33 | 0.190 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2022 | 772 | 0.190 |
Why?
|
Albinism, Oculocutaneous | 1 | 2020 | 17 | 0.190 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2020 | 19 | 0.190 |
Why?
|
Postoperative Complications | 2 | 2020 | 15244 | 0.190 |
Why?
|
Hamartoma | 1 | 2022 | 234 | 0.180 |
Why?
|
Medicare | 3 | 2023 | 6532 | 0.180 |
Why?
|
Pigmentation | 1 | 2020 | 148 | 0.180 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2023 | 406 | 0.180 |
Why?
|
Internship and Residency | 1 | 2020 | 5774 | 0.180 |
Why?
|
Refractive Errors | 1 | 2021 | 142 | 0.180 |
Why?
|
Wet Macular Degeneration | 1 | 2022 | 146 | 0.180 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2020 | 79 | 0.180 |
Why?
|
Scientific Misconduct | 1 | 2020 | 71 | 0.180 |
Why?
|
Central Nervous System Cysts | 1 | 2020 | 58 | 0.180 |
Why?
|
Ciliary Arteries | 1 | 2019 | 17 | 0.180 |
Why?
|
Eye Burns | 1 | 2020 | 102 | 0.180 |
Why?
|
Dyskeratosis Congenita | 1 | 2020 | 72 | 0.180 |
Why?
|
Frizzled Receptors | 1 | 2020 | 91 | 0.180 |
Why?
|
Telomere-Binding Proteins | 1 | 2020 | 116 | 0.180 |
Why?
|
Retinal Pigment Epithelium | 2 | 2022 | 302 | 0.180 |
Why?
|
Retinal Vein | 1 | 2019 | 47 | 0.170 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2020 | 68 | 0.170 |
Why?
|
Muscle Spasticity | 1 | 2020 | 154 | 0.170 |
Why?
|
Orbital Neoplasms | 1 | 2021 | 225 | 0.170 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 343 | 0.170 |
Why?
|
Glaucoma Drainage Implants | 1 | 2020 | 116 | 0.170 |
Why?
|
Regional Blood Flow | 2 | 2019 | 1525 | 0.170 |
Why?
|
Eye Diseases, Hereditary | 1 | 2020 | 117 | 0.170 |
Why?
|
X Chromosome | 1 | 2022 | 815 | 0.160 |
Why?
|
Retinal Artery | 1 | 2019 | 111 | 0.160 |
Why?
|
Aged | 14 | 2023 | 162944 | 0.160 |
Why?
|
Neonatal Screening | 1 | 2023 | 591 | 0.160 |
Why?
|
Infant | 8 | 2023 | 35070 | 0.160 |
Why?
|
Parasites | 1 | 2020 | 161 | 0.160 |
Why?
|
Ataxia | 1 | 2020 | 304 | 0.160 |
Why?
|
Publications | 1 | 2020 | 195 | 0.160 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 238 | 0.150 |
Why?
|
Prosthesis Design | 2 | 2022 | 2110 | 0.150 |
Why?
|
Orbital Fractures | 1 | 2018 | 110 | 0.140 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1679 | 0.140 |
Why?
|
Bacteriological Techniques | 1 | 2017 | 276 | 0.140 |
Why?
|
Pandemics | 3 | 2020 | 8328 | 0.140 |
Why?
|
Anesthesia, Conduction | 1 | 2019 | 238 | 0.140 |
Why?
|
United States | 6 | 2023 | 69693 | 0.140 |
Why?
|
Recombinant Fusion Proteins | 2 | 2022 | 3770 | 0.140 |
Why?
|
Blindness | 1 | 2020 | 615 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1059 | 0.130 |
Why?
|
Middle Aged | 19 | 2023 | 213127 | 0.130 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2016 | 73 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2023 | 1155 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 546 | 0.130 |
Why?
|
Cataract Extraction | 1 | 2019 | 482 | 0.130 |
Why?
|
Eye Diseases | 1 | 2020 | 670 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1720 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1507 | 0.120 |
Why?
|
Oculomotor Muscles | 1 | 2018 | 371 | 0.120 |
Why?
|
Adult | 18 | 2023 | 213712 | 0.120 |
Why?
|
Drug Costs | 1 | 2021 | 1104 | 0.120 |
Why?
|
Intraoperative Complications | 1 | 2020 | 1188 | 0.110 |
Why?
|
Cataract | 1 | 2019 | 833 | 0.110 |
Why?
|
Anticonvulsants | 1 | 2023 | 1914 | 0.110 |
Why?
|
Nerve Fibers | 1 | 2016 | 688 | 0.110 |
Why?
|
Cornea | 1 | 2020 | 1497 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1513 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1066 | 0.100 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 5385 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2019 | 1164 | 0.100 |
Why?
|
Child, Preschool | 3 | 2023 | 40955 | 0.100 |
Why?
|
Calcinosis | 1 | 2020 | 1497 | 0.100 |
Why?
|
Retinal Ganglion Cells | 1 | 2016 | 771 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19862 | 0.090 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39004 | 0.090 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2699 | 0.090 |
Why?
|
Dental Implants | 1 | 2018 | 749 | 0.090 |
Why?
|
Time Factors | 3 | 2020 | 40054 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.080 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 24913 | 0.080 |
Why?
|
Seizures | 1 | 2020 | 2851 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2020 | 3527 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57683 | 0.070 |
Why?
|
Telemedicine | 1 | 2023 | 2853 | 0.070 |
Why?
|
Benchmarking | 2 | 2023 | 1038 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.060 |
Why?
|
Phenotype | 1 | 2022 | 16331 | 0.060 |
Why?
|
Vitreous Hemorrhage | 1 | 2023 | 48 | 0.060 |
Why?
|
Young Adult | 5 | 2020 | 56350 | 0.060 |
Why?
|
Klebsiella | 1 | 2022 | 48 | 0.060 |
Why?
|
Scleral Buckling | 1 | 2023 | 84 | 0.060 |
Why?
|
Ophthalmoscopy | 1 | 2023 | 176 | 0.060 |
Why?
|
Disease Progression | 1 | 2019 | 13256 | 0.050 |
Why?
|
Thailand | 1 | 2023 | 296 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8455 | 0.050 |
Why?
|
Risk Factors | 3 | 2023 | 72145 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2023 | 62966 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7645 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2022 | 246 | 0.050 |
Why?
|
Vitreous Body | 1 | 2022 | 389 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 402 | 0.050 |
Why?
|
Optics and Photonics | 1 | 2022 | 321 | 0.050 |
Why?
|
Injections, Intraocular | 1 | 2020 | 30 | 0.050 |
Why?
|
Aging | 1 | 2019 | 8626 | 0.040 |
Why?
|
Axial Length, Eye | 1 | 2019 | 31 | 0.040 |
Why?
|
Eye | 1 | 2023 | 728 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 317 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8829 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 29717 | 0.040 |
Why?
|
Personnel Selection | 1 | 2020 | 189 | 0.040 |
Why?
|
Orbit | 1 | 2021 | 427 | 0.040 |
Why?
|
Zygoma | 1 | 2018 | 51 | 0.040 |
Why?
|
Social Responsibility | 1 | 2021 | 389 | 0.040 |
Why?
|
Normal Distribution | 1 | 2019 | 280 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2020 | 981 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 85649 | 0.040 |
Why?
|
Intraocular Pressure | 1 | 2023 | 1274 | 0.040 |
Why?
|
Reading | 1 | 2021 | 557 | 0.040 |
Why?
|
Diplopia | 1 | 2018 | 199 | 0.040 |
Why?
|
Prognosis | 3 | 2023 | 29010 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2022 | 2557 | 0.040 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2018 | 232 | 0.030 |
Why?
|
Vision Disorders | 1 | 2023 | 1057 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2019 | 1423 | 0.030 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2018 | 341 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12958 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1911 | 0.030 |
Why?
|
Educational Measurement | 1 | 2020 | 1206 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 20928 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2533 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2019 | 2451 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3800 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2978 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3062 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4147 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11363 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3439 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20086 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8297 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15056 | 0.020 |
Why?
|
Prospective Studies | 2 | 2019 | 53187 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7153 | 0.020 |
Why?
|
Algorithms | 1 | 2023 | 13853 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12705 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 21719 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35342 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168561 | 0.010 |
Why?
|